Single nucleotide polymorphisms in the D-loop region of mitochondrial DNA is associated with renal cell carcinoma outcome

Mitochondrial DNA

Volumn 26, Issue 2, 2015, Pages 224-226

  Bai, Yaling ^a   Guo, Zhanjun ^a   Xu, Jinsheng ^a   Liu, Shufeng ^a   Zhang, Junxia ^a   Cui, Liwen ^a   Zhang, Huiran ^a   Zhang, Shenglei ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

D loop; MtDNA; Outcome; Renal cell carcinoma; SNP

Indexed keywords

GENOMIC DNA; MITOCHONDRIAL DNA;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SURVIVAL; CASE CONTROL STUDY; D LOOP; DNA EXTRACTION; DNA STRUCTURE; FEMALE; GENE FREQUENCY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; CHEMISTRY; GENETICS; KIDNEY TUMOR; MIDDLE AGED; MORTALITY; SURVIVAL RATE;

CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; DNA, MITOCHONDRIAL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SURVIVAL RATE;

EID: 84926488275     PISSN: 19401736     EISSN: 19401744     Source Type: Journal    
DOI: 10.3109/19401736.2013.825772     Document Type: Article

References (23)

1. Bai RK, Leal SM, Covarrubias D, Liu A, Wong LJ. (2007). Mitochondrial genetic background modifies breast cancer risk. Cancer Res 67: 4687-94.
2. Bandy B, Davison AJ. (1990). Mitochondrial mutations may increase oxidative stress: Implications for carcinogenesis and aging? Free Radic Biol Med 8:523-39.
3. Beal MF. (1996). Mitochondria, free radicals, and neurodegeneration. Curr Opin Neurobiol 6:661-6.
4. Dement GA, Maloney SC, Reeves R. (2007). Nuclear HMGA1 nonhistone chromatin proteins directly influence mitochondrial transcription, maintenance, and function. Exp Cell Res 313:77-87.
5. Dimauro S, Schon EA. (2001). Mitochondrial DNA mutations in human disease. Am J Med Genet 106:18-26.
6. Ding C, Li R, Wang P, Jin P, Li S, Guo Z. (2012). Identification of sequence polymorphisms in the D-loop region of mitochondrial DNA as a risk factor for lung cancer. Mitochondr DNA 23:251-4.
7. Gille JJ, Joenje H. (1992). Cell culture models for oxidative stress: Superoxide and hydrogen peroxide versus normobaric hyperoxia. Mutat Res 275:405-14.
8. Lee HC, Yin PH, Lin JC, Wu CC, Chen CY, Wu CW, Chi CW, et al. (2005). Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci 1042:109-22.
9. Liu S-A, Jiang R-S, Chen F-J, Wang W-Y, Lin J-C. (2011). Somatic mutations in the D-loop of mitochondrial DNA in oral squamous cell carcinoma. Eur Arch Oto-Rhino-Laryngol 269:1665-70.
10. Navaglia F, Basso D, Fogar P, Sperti C, Greco E, Zambon CF, Stranges A, et al. (2006). Mitochondrial DNA D-loop in pancreatic cancer: Somatic mutations are epiphenomena while the germline 16519 T variant worsens metabolism and outcome. Am J Clin Pathol 126:593-601.
11. Remon J, Lianes P, Martinez S. (2012). Brain metastases from renal cell carcinoma. Should we change the current standard? Cancer Treat Rev 38:249-57.
12. Salehipoor M, Khezri A, Behzad-behbahani A, Geramizadeh B, Rahsaz M, Aghdaei M, Afrasiabi MA. (2012). Role of viruses in renal cell carcinoma. Saudi J Kidney Dis Transpl 23:53-7.
13. Shigenaga MK, Hagen TM, Ames BN. (1994). Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 91:10771-8.
14. Staehler M, Rohrmann K, Haseke N, Stief CG, Siebels M. (2005). Targeted agents for the treatment of advanced renal cell carcinoma. Curr Drug Targets 6:835-46.
15. Stoneking M. (2000). Hypervariable sites in the mtDNA control region are mutational hotspots. Am J Hum Genet 67:1029-32.
16. Taanman JW. (1999). The mitochondrial genome: Structure, transcription, translation and replication. Biochim Biophys Acta 1410:103-23.
17. Tran HT, Liu Y, Zurita AJ, Lin Y, Baker-neblett KL, Martin AM, Figlin RA, et al. (2012). Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: A retrospective analysis of phase 2 and phase 3 trials. Lancet Oncol 13:827-37.
18. Wang L, Bamlet WR, de andrade M, Boardman LA, Cunningham JM, Thibodeau SN, Petersen GM. (2007). Mitochondrial genetic polymorphisms and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev 16:1455-9.
19. Wang L, Mcdonnell SK, Hebbring SJ, Cunningham JM, St sauver J, Cerhan JR, Isaya G, et al. (2008). Polymorphisms in mitochondrial genes and prostate cancer risk. Cancer Epidemiol Biomark Prev 17: 3558-66.
20. Zhang R, Wang R, Zhang F, Wu C, Fan H, Li Y, Wang C, Guo Z. (2010a). Single nucleotide polymorphisms in the mitochondrial displacement loop and outcome of esophageal squamous cell carcinoma. J Exp Clin Cancer Res 29:155.
21. Zhang R, Zhang F, Wang C, Wang S, Shiao YH, Guo Z. (2010b). Identification of sequence polymorphism in the D-loop region of mitochondrial DNA as a risk factor for hepatocellular carcinoma with distinct etiology. J Exp Clin Cancer Res 29:130.
22. Zhang J, Guo Z, Bai Y, Cui L, Zhang H, Zhang S, Xu J. (2013). Identification of sequence polymorphisms in the displacement loop region of mitochondrial DNA as a risk factor for renal cell carcinoma. Biomed Rep 1:563-6.
23. Zhao P, Dai M, Chen W, Li N. (2010). Cancer trends in China. Jpn J Clin Oncol 40:281-5.